Exelixis
EXEL
#1324
Rank
ยฃ12.96 B
Marketcap
ยฃ53.15
Share price
-0.43%
Change (1 day)
62.66%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company